Search for: "Rebecca Schiller"
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
10 Mar 2020, 9:30 pm
PakAnti-Competition Regulation, by Anne Fleming, with a comment by Rebecca Haw AllensworthThe Curious Origins of Airline Deregulation: Economic Deregulation and the American Left, by Reuel Schiller, with a comment by Lily GeismerA Premature Postmortem on the Chicago School of Antitrust, by Daniel A. [read post]
29 Apr 2012, 6:06 am
Lawrence Schiller. [read post]
3 Aug 2014, 7:56 am
Snow, Noel Coward, Rebecca West, Sir Philip Gibbs and Norman Angeli.... [read post]
3 Apr 2019, 10:32 pm
Sophia Lee and Reuel Schiller then gave me the language of administrative constitutionalism with which to describe my findings.Writing. [read post]
10 Aug 2017, 8:00 am
Meena Gujrati, and her employer, Central Illinois Pathology, were named as defendants in a medical-malpractice lawsuit brought by Rebecca Gapinski who alleged that this doctor misdiagnosed Daniel Gapinski’s brain tumor as being benign. [read post]
13 Sep 2020, 9:30 pm
Eastern Standard Time.American Society for Legal History, Virtual Mini-Conference November 13-14, 2020Friday, November 13, 202010:30-12:00: Panel 1 – The Everyday Materials of Colonial Legal SpacesIntroductionKalyani Ramnath, Harvard University“Half Real: Space, Imagination and the Juzgado de Indios in Spanish America”Bianca Premo, Florida International University“Paper, People, Cloth: Mixed Courtrooms and Materiality in Colonial Indonesia”Sanne Ravensbergen, Leiden… [read post]
29 Jun 2015, 8:00 am
Gapinski’s wife, Rebecca. [read post]
12 Dec 2013, 9:15 am
Schiller’s comments also bore this out.Q: what is a remix? [read post]
21 Mar 2011, 7:39 am
., Rebecca Worthington, Esq. and the rest of the team from Squire Sanders' Washington, DC Office for their representation of Trident Enterprises in Trident v. [read post]
19 Aug 2013, 4:30 am
Zurier, Rebecca. [read post]
25 Nov 2008, 2:00 pm
Justice Ramos saved his angriest words for Starr's counsel, Rebecca Fine of Schindler, Cohen & Hochman. [read post]
21 Aug 2019, 1:09 pm
(Center for History and Economics, Harvard University)Moderators: Elizabeth Lhost, University of Wisconsin-Madison (elizabeth@wisc.edu) and Emma Rothschild, Harvard University (rothsch@fas.harvard.edu)Debjani Bhattacharya, Drexel University (db893@drexel.edu)South Asia 1Julia Stephens, Rutgers University (julia.stephens@rutgers.edu)South Asia 2Tatiana Seijas, Rutgers University (tatiana.seijas@rutgers.edu)Latin America 3Michelle… [read post]
15 Aug 2019, 9:30 pm
Rebecca Roanhorse? [read post]
17 Apr 2024, 7:05 am
Rebecca Manochio—Manochio is, according to her LinkedIn, an executive assistant at the Trump Organization. [read post]
24 Aug 2019, 6:30 am
Civil WarKalyani Ramnath, Harvard University (kalyaniramnath@fas.harvard.edu) Boats in a Storm: Law and Displacement in Postwar South AsiaEvan Taparata, University of Pennsylvania (taparata@sas.upenn.edu) State of Refuge: Refugee Law and the Modern United StatesAdnan Zulfiqar, Rutgers Law School (adnan.zulfiqar@rutgers.edu) Collective Duties in Islamic Law: The Moral Community, State Authority, and Ethical Speculation in the late 9th to the 14th Centuries CEConvener: Reuel… [read post]
4 Sep 2012, 11:06 am
Welcome by University of Georgia School of Law Dean Rebecca H. [read post]
17 Apr 2013, 4:37 pm
” Banks introduces three different historical cases: the 1995 Body Worlds exhibit by Gunther von Hagens; the skeleton of an enslaved man (whose name was Fortune) who died in 1798 and was being studied by the anthropology faculty and students at Quinnipiac University; and perhaps the best known of the three, the story of Henrietta Lacks as recently discussed by Rebecca Skloots in her book The Immortal Life of Henrietta Lacks (2010), that together raise for her the question of whether… [read post]
9 Mar 2020, 1:21 pm
FDA and FTC Approaches to Help Ensure Truthful and Non‐misleading Advertising and Promotional Communications Lowell Schiller, Principal Associate Commissioner for Policy, FDA: have seen troubling communications suggesting biosimilars are less safe/less effective than reference products or that there may be clinically meaningful differences b/t them when biosimilars can’t be approved unless there are no clinically meaningful differences. [read post]
